Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study (Q40309560)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 October 2011
edit
Language Label Description Also known as
English
Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study
scientific article published on 13 October 2011

    Statements

    Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study (English)
    Gabriela Senti
    Seraina von Moos
    Fabian Tay
    Nicole Graf
    Theodor Sonderegger
    Pål Johansen
    13 October 2011
    128-135

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit